AlphaMark Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35,591
Closed -$272K 706
2024
Q3
$272K Buy
+35,591
New +$328K 0.09% 208
2024
Q2
Sell
-28,194
Closed -$337K 808
2024
Q1
$337K Buy
28,194
+8,351
+42% +$92.8K 0.12% 133
2023
Q4
$214K Buy
19,843
+2,374
+14% +$28.9K 0.08% 215
2023
Q3
$242K Buy
+17,469
New +$256K 0.1% 153

Other funds holding PTEN

AlphaMark Advisors's PTEN Position: Q4 2024 in Review

AlphaMark Advisors sold out of Patterson-UTI (PTEN) in Q4 2024, closing a stake of 35,591 shares — an estimated $272K sold.

AlphaMark Advisors first reported a position in PTEN in Q3 2023 and held it in 4 quarters. The position peaked at $337K in Q1 2024. 365 funds tracked by Wall St. Rank hold PTEN as of Q4 2024.

  • AlphaMark Advisors reported no remaining Patterson-UTI position as of Q4 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 35,591 Patterson-UTI shares in Q4 2024, an estimated $272K.
  • AlphaMark Advisors first reported a position in Patterson-UTI in Q3 2023 and held it in 4 quarters.
  • AlphaMark Advisors's Patterson-UTI position peaked at $337K in Q1 2024.
  • 365 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.